$PRPO
Precipio, Inc.

2015 Q2 Form 10-Q Financial Statement

#000104396115000011 Filed on May 14, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $442.0K $750.0K $6.251M
YoY Change -93.47% -88.0% -15.23%
Cost Of Revenue $465.0K $465.0K $3.757M
YoY Change -89.36% -87.62% -8.79%
Gross Profit -$23.00K $285.0K $2.494M
YoY Change -100.96% -88.57% -23.38%
Gross Profit Margin -5.2% 38.0% 39.9%
Selling, General & Admin $1.908M $1.804M $5.288M
YoY Change -65.7% -65.89% -16.21%
% of Gross Profit 632.98% 212.03%
Research & Development $468.0K $451.0K $745.0K
YoY Change -40.38% -39.46% -2.49%
% of Gross Profit 158.25% 29.87%
Depreciation & Amortization $558.0K $41.00K $493.0K
YoY Change 14.34% -91.68% -33.74%
% of Gross Profit 14.39% 19.77%
Operating Expenses $2.376M $2.255M $6.033M
YoY Change -62.57% -62.62% -14.73%
Operating Profit -$2.399M -$1.970M -$3.539M
YoY Change -39.34% -44.33% -7.36%
Interest Expense -$460.0K -$340.0K -$130.0K
YoY Change -1020.0% 161.54% -152.0%
% of Operating Profit
Other Income/Expense, Net $0.00 -$13.00K $0.00
YoY Change -100.0%
Pretax Income -$2.855M -$2.318M -$3.671M
YoY Change -26.81% -36.86% 4.29%
Income Tax -$1.000K $0.00 $505.0K
% Of Pretax Income
Net Earnings -$3.275M -$3.041M -$4.176M
YoY Change -15.87% -27.18% 16.45%
Net Earnings / Revenue -740.95% -405.47% -66.81%
Basic Earnings Per Share
Diluted Earnings Per Share -$109.3M -$152.0M -$209.0M
COMMON SHARES
Basic Shares Outstanding 12.16M shares 11.86M shares 7.354M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.310M $5.380M $1.740M
YoY Change 94.12% 209.2% -77.49%
Cash & Equivalents $2.309M $5.379M $1.743M
Short-Term Investments
Other Short-Term Assets $826.0K $1.524M $693.0K
YoY Change -6.03% 119.91% -41.52%
Inventory $2.619M $2.984M $4.053M
Prepaid Expenses
Receivables $9.719M $8.345M $6.191M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.47M $18.23M $12.68M
YoY Change 15.67% 43.79% -41.28%
LONG-TERM ASSETS
Property, Plant & Equipment $1.320M $1.295M $1.909M
YoY Change -28.1% -32.16% -7.82%
Goodwill $6.918M $6.918M $6.918M
YoY Change 0.0% 0.0% 0.0%
Intangibles $7.549M $7.854M $8.899M
YoY Change -12.88% -11.74% -14.12%
Long-Term Investments
YoY Change
Other Assets $149.0K $192.0K $311.0K
YoY Change -49.49% -38.26% -31.35%
Total Long-Term Assets $15.94M $16.26M $18.04M
YoY Change -10.04% -9.86% -8.92%
TOTAL ASSETS
Total Short-Term Assets $15.47M $18.23M $12.68M
Total Long-Term Assets $15.94M $16.26M $18.04M
Total Assets $31.41M $34.49M $30.72M
YoY Change 1.02% 12.29% -25.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.743M $5.008M $2.661M
YoY Change 34.1% 88.2% 75.53%
Accrued Expenses $2.698M $2.368M $1.809M
YoY Change 32.25% 30.9% -35.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.825M $523.0K $0.00
YoY Change 308.83% -100.0%
Total Short-Term Liabilities $13.31M $11.07M $8.046M
YoY Change 36.39% 37.55% -15.25%
LONG-TERM LIABILITIES
Long-Term Debt $4.850M $7.925M $3.758M
YoY Change -21.91% 110.88% -38.08%
Other Long-Term Liabilities $1.762M $1.703M $1.855M
YoY Change -7.12% -8.19% 46.52%
Total Long-Term Liabilities $6.612M $9.628M $5.613M
YoY Change -18.45% 71.53% -23.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.31M $11.07M $8.046M
Total Long-Term Liabilities $6.612M $9.628M $5.613M
Total Liabilities $20.49M $24.45M $16.43M
YoY Change -1.23% 48.83% -5.22%
SHAREHOLDERS EQUITY
Retained Earnings -$186.8M -$187.0M -$172.9M
YoY Change 5.46% 8.13% 11.15%
Common Stock $123.0K $119.0K $73.00K
YoY Change 68.49% 63.01% -91.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.92M $10.05M $14.29M
YoY Change
Total Liabilities & Shareholders Equity $31.41M $34.49M $30.72M
YoY Change 1.02% 12.29% -25.8%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$3.275M -$3.041M -$4.176M
YoY Change -15.87% -27.18% 16.45%
Depreciation, Depletion And Amortization $558.0K $41.00K $493.0K
YoY Change 14.34% -91.68% -33.74%
Cash From Operating Activities -$2.500M -$3.513M -$3.866M
YoY Change -26.25% -9.13% 15.96%
INVESTING ACTIVITIES
Capital Expenditures -$180.0K $10.00K $45.00K
YoY Change 200.0% -77.78% -48.28%
Acquisitions
YoY Change
Other Investing Activities -$60.00K -$10.00K $48.00K
YoY Change 500.0% -120.83% -62.2%
Cash From Investing Activities -$240.0K $0.00 -$93.00K
YoY Change 200.0% -100.0% -91.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.389M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -340.0K $7.293M $4.071M
YoY Change -111.68% 79.15% -46.91%
NET CHANGE
Cash From Operating Activities -2.500M -$3.513M -$3.866M
Cash From Investing Activities -240.0K $0.00 -$93.00K
Cash From Financing Activities -340.0K $7.293M $4.071M
Net Change In Cash -3.080M $3.780M $112.0K
YoY Change 450.0% 3275.0% -96.58%
FREE CASH FLOW
Cash From Operating Activities -$2.500M -$3.513M -$3.866M
Capital Expenditures -$180.0K $10.00K $45.00K
Free Cash Flow -$2.320M -$3.523M -$3.911M
YoY Change -30.33% -9.92% 14.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12161156 shares
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC
CY2015Q1 tbio Accounts Receivable General Payment Terms1
AccountsReceivableGeneralPaymentTerms1
P30D
CY2015Q1 tbio Accounts Receivable International Extended Payment Terms Greaterthan1
AccountsReceivableInternationalExtendedPaymentTermsGreaterthan1
P90D
CY2014Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
115432 shares
CY2015Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
1208491 shares
CY2015Q1 tbio Debt Instrument Numberof Additional Accredited Investors
DebtInstrumentNumberofAdditionalAccreditedInvestors
7 investor
CY2015Q1 tbio Effective Tax Rate Reconciliation Permanent Differences Goodwill Amortization
EffectiveTaxRateReconciliationPermanentDifferencesGoodwillAmortization
100000 USD
CY2015Q1 tbio Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point
FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint
0.25
CY2015Q1 tbio Finite Lived Intangible Assets Amortization Expense Current Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseCurrentFiscalYear
1400000 USD
CY2014Q4 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
3877000 USD
CY2015Q1 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
3875000 USD
CY2014Q1 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-182000 USD
CY2015Q1 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-190000 USD
CY2014Q1 tbio Inventory Additions
InventoryAdditions
55000 USD
CY2015Q1 tbio Inventory Additions
InventoryAdditions
0 USD
CY2014Q1 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
5000 USD
CY2015Q1 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
27000 USD
CY2015Q1 tbio Issuance Of Warrants Expected Exercise Period
IssuanceOfWarrantsExpectedExercisePeriod
P1Y10M10D
CY2014Q1 tbio Other Income Expense
OtherIncomeExpense
-132000 USD
CY2015Q1 tbio Other Income Expense
OtherIncomeExpense
-348000 USD
CY2014 tbio Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
6905000 USD
CY2014Q1 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
673000 USD
CY2015Q1 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
1532000 USD
CY2014Q1 tbio Stock Warrants Revaluation
StockWarrantsRevaluation
50000 USD
CY2015Q1 tbio Stock Warrants Revaluation
StockWarrantsRevaluation
-145000 USD
CY2015Q1 tbio Working Capital
WorkingCapital
7200000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4871000 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5008000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7627000 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8345000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2550000 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2368000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13764000 USD
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13891000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
340000 USD
CY2015Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1067000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1688000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
306000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189680000 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
196540000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
977000 USD
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
134000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3838000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3540000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7947000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9193000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
971000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
286000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5523975 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8248953 shares
CY2014Q1 us-gaap Assets
Assets
30717000 USD
CY2014Q4 us-gaap Assets
Assets
30006000 USD
CY2015Q1 us-gaap Assets
Assets
34491000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
13432000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
18232000 USD
CY2014Q1 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2015Q1 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1626000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1743000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1609000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5379000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
117000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3770000 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
10.25
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
11.73
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
10.86
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
7.56
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
9.59
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1387685 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1212665 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1309785 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1881396 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1483161 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4093477 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8084471 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11857078 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8084471 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11857078 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
81000 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
119000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4164000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3075000 USD
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3757000 USD
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3539000 USD
CY2014Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7837000 USD
CY2015Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
8448000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1035000 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1121000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
100000 USD
CY2015Q1 us-gaap Depreciation
Depreciation
100000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
493000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
553000 USD
CY2014Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3130000 USD
CY2015Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3461000 USD
CY2014 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1144000 USD
CY2015Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
331000 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
5000 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-10000 USD
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0150
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1129000 USD
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
980000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
500000 USD
CY2014Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-50000 USD
CY2015Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
145000 USD
CY2015Q1 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P2Y0M
CY2015Q1 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.89
CY2015Q1 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0053
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5970000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6270000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
900000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1100000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1400000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1400000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13934000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14124000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7964000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7854000 USD
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 USD
CY2015Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 USD
CY2014Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2015Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-14000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
6918000 USD
CY2015Q1 us-gaap Goodwill
Goodwill
6918000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
2494000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
2974000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3671000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2995000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
505000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-203000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
144000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1542000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1734000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-509000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-41000 USD
CY2014Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
CY2015Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
60000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
149000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28000 USD
CY2014Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-70000 USD
CY2015Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-178000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-263000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
591000 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7964000 USD
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7854000 USD
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-182000 USD
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-190000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
157000 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
67000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2139000 USD
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2108000 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
3633000 USD
CY2015Q1 us-gaap Inventory Gross
InventoryGross
3585000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
3005000 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
2984000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
799000 USD
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
849000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
628000 USD
CY2015Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
601000 USD
CY2014Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1302000 USD
CY2015Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1263000 USD
CY2014Q1 us-gaap Inventory Write Down
InventoryWriteDown
55000 USD
CY2015Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2014Q4 us-gaap Liabilities
Liabilities
23453000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
24446000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30006000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34491000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11115000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11067000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
462000 USD
CY2015Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
523000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7375000 USD
CY2015Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7925000 USD
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
11369000 USD
CY2015Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
11311000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4071000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7293000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3866000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3513000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-4176000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-13942000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3041000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4406000 USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3372000 USD
CY2015Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
6033000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
5621000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3539000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2647000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
200000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
500000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
800000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
900000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
600000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
800000 USD
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1191000 USD
CY2015Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1524000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
210000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
192000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12000 USD
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-50000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34000 USD
CY2014Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
192000 USD
CY2015Q1 us-gaap Other Inventory Demo
OtherInventoryDemo
214000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1068000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5054000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
331000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
114000 USD
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1703000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13000 USD
CY2014Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
48000 USD
CY2015Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-10000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000 USD
CY2014Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
230000 USD
CY2015Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
331000 USD
CY2014Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
230000 USD
CY2015Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
331000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4029502 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4029502 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4029502 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4029502 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
40000 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
40000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6389000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
6970000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2014Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1400000 USD
CY2015Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
923000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15246000 USD
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15186000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1482000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1295000 USD
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
673000 USD
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
988000 USD
CY2015Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
1200000 USD
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
57000 USD
CY2015Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
19000 USD
CY2014Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4242000 USD
CY2015Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
745000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
567000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-183588000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-186960000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
6251000 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
6513000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5288000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y3M25D
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.86
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0161
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
308870 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.83
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
46399 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6141 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
199080 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
12350 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
685984 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
645794 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.56
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.22
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
604285 shares
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.20
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.25
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.01
CY2015Q1 us-gaap Share Price
SharePrice
1.44
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y1M15D
CY2015Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
375000 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2361000 USD
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6389000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
11446000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
6553000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
10045000 USD
CY2014Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0833
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
145000 USD
CY2015Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
290000 USD
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7353695 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9392851 shares
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these condensed consolidated financial statements.</font></div></div>

Files In Submission

Name View Source Status
0001043961-15-000011-index-headers.html Edgar Link pending
0001043961-15-000011-index.html Edgar Link pending
0001043961-15-000011.txt Edgar Link pending
0001043961-15-000011-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20150331.xml Edgar Link completed
tbio-20150331.xsd Edgar Link pending
tbio-20150331x10q.htm Edgar Link pending
tbio-20150331_cal.xml Edgar Link unprocessable
tbio-20150331_def.xml Edgar Link unprocessable
tbio-20150331_lab.xml Edgar Link unprocessable
tbio-20150331_pre.xml Edgar Link unprocessable
tbio-ex311_20150331x10q.htm Edgar Link pending
tbio-ex321_20150331x10q.htm Edgar Link pending